# Hinge Health (HNGE) — News

HNGE · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/hnge/news

## Recent headlines

- [CMA CGM - From 2029, this facility, developed by Engie, will supply 7,000 tonnes of biomethane (equivalent to 100 GWh) each year to the CMA CGM fleet](https://www.ainvest.com/news/cma-cgm-2029-facility-developed-engie-supply-7-000-tonnes-biomethane-equivalent-100-gwh-year-cma-cgm-fleet-2610) — AInvest Wire, Oct 13, 2026
  CMA CGM has announced a new initiative in its ongoing efforts to achieve carbon neutrality by 2050, with a facility developed by Engie set to supply 7,000 tonnes of biomethane annually, equivalent to 100 gigawatt-hours (GWh), to the CMA CGM fleet starting in 2029. This development aligns with the…
- [Henge shareholders incl. President Ogura to sell shares](https://www.ainvest.com/news/henge-shareholders-incl-president-ogura-sell-shares-2610) — AInvest Wire, Oct 2, 2026
  Hinge Health shareholders, including President Ogura, are set to sell shares in the coming months, according to recent filings and market activity. Institutional ownership of Hinge Health has grown significantly, with 280 institutional investors holding 73.2% of outstanding stock , up from 71.4% in…
- [Hinge Health, Inc.: Needham raises target price to $115 from $97](https://www.ainvest.com/news/hinge-health-needham-raises-target-price-115-97-2609) — AInvest Wire, Sep 30, 2026
- [Hinge Health, Inc.: BofA global research reinstates coverage with buy rating; price objective $110](https://www.ainvest.com/news/hinge-health-bofa-global-research-reinstates-coverage-buy-rating-price-objective-110-2609) — AInvest Wire, Sep 29, 2026
- [Hinge Health, Inc.: Stifel raises target price to $115 from $96](https://www.ainvest.com/news/hinge-health-stifel-raises-target-price-115-96-2609) — AInvest Wire, Sep 8, 2026
  Stifel Nicolaus has raised its price target for Hinge Health, Inc. (NYSE: HNGE) to $115 from $96, while maintaining its "Buy" rating . The adjustment follows the company’s recent outperformance, driven by strong second-quarter earnings and strategic expansion into new care categories, including…

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).